Episode
The $60 Billion Alternative Asset Most Investors Have Never Heard Of - Medical Finance and nvstIRA
- Podcast
- Investor's Row Podcast
- Published
- Mar 25, 2026
- Duration seconds
- 2631
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/CSN2560247173.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/investor-s-row-podcast-7074838/episodes/the-60-billion-alternative-asset-most-investors-have-never-heard-of-medical-finance-and-nvstira/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/investor-s-row-podcast-7074838/the-60-billion-alternative-asset-most-investors-have-never-heard-of-medical-finance-and-nvstira.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this podcast, Roberta Valentine, founder of nvstIRA, breaks down medical receivables finance — a $60B alternative asset class that most self-directed IRA investors have never considered. If you're tired of tenant headaches, syndication lockups, and single-digit returns on your investments, this is the conversation you need to hear. What we cover: - Why self-directed IRA investors feel "in control" but actually aren't - The #1 mistake people make when funding alternative investments - How medical receivables work (and why insurance-backed collateral is safer than you think) - PFD Capital's structure: $25K minimum, quarterly dividends, 12-month liquidity - Due diligence checklist for ANY alternative investment - Why private equity is outperforming real estate in 2025+ Connect with Roberta via text at 216-337-3231 or learn more at http://nvstira.com